Launched 9 omic-products
Championed 4 bio-ventures,
including $189 million IPO
Valued 5 biotech-business
opportunities @ $1.7 billion
Completed 65 BD alliances
+ 3 M&A transactions
“A roadmap …
communicates visions,
attracts resources,
stimulates investigations,
& monitors progress …”
– Robert Galvin (Science, 1998)